Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

COVID-19 as a possible risk factor for poor prognosis in systemic sclerosis

Show simple item record

dc.contributor.author Agachi, Svetlana
dc.contributor.author Popa, Serghei
dc.contributor.author Rotaru, Larisa
dc.contributor.author Russu, Eugeniu
dc.contributor.author Dutca, Lucia
dc.contributor.author Meleșco, Irina
dc.contributor.author Stog, Valeria
dc.date.accessioned 2025-07-23T08:11:20Z
dc.date.available 2025-07-23T08:11:20Z
dc.date.issued 2025
dc.identifier.citation AGACHI, Svetlana; Serghei POPA; Larisa ROTARU; Eugeniu RUSSU; Lucia DUTCA; Irina MELEȘCO și Valeria STOG. COVID-19 as a possible risk factor for poor prognosis in systemic sclerosis. In: Revista de Ştiinţe ale Sănătăţii din Moldova = Moldovan Journal of Health Sciences. 2025, vol. 12, nr. 2, pp. 71-74. ISSN 2345-1467. DOI: https://doi.org/10.52645/MJHS.2025.2.10 en_US
dc.identifier.issn 2345-1467
dc.identifier.uri https://doi.org/10.52645/MJHS.2025.2.10
dc.identifier.uri https://repository.usmf.md/handle/20.500.12710/30965
dc.description.abstract Introduction. Scleroderma Renal Crisis (SRC) is a life-threatening complication of systemic sclerosis (SSc), traditionally associated with anti-RNA polymerase III antibodies, corticosteroid use, and diffuse skin involvement. However, the role of COVID-19 as a potential trigger for SRC remains poorly understood. This study explores the occurrence of COVID-19-associated SRC, focusing on its clinical presentation, underlying risk factors, and outcomes. Case presentation. We present a case series of two unvaccinated patients with systemic sclerosis who developed SRC following COVID-19 infection, despite the absence of traditional risk factors. Clinical features, laboratory findings, renal histopathology, and disease progression were analyzed to assess potential mechanisms linking SARS-CoV-2 infection to SRC onset. Both patients developed abrupt-onset malignant hypertension and acute kidney injury after supporting the COVID-19. Neither patient had a history of corticosteroid use or known anti-RNA polymerase III positivity, suggesting an alternative mechanism of SRC activation. Notably, both cases had pre-existing renal anomalies (renal developmental abnormality and prior nephrectomy), which may have contributed to increased susceptibility. Despite aggressive management, both patients developed dialysis-dependent renal failure and succumbed to SRC-related complications. Conclusions. Our findings highlight COVID-19 as a potential trigger for SRC, possibly through endothelial dysfunction, inflammatory cytokine storms, and renal microangiopathy. The presence of pre-existing kidney conditions may further predispose SSc patients to SRC following SARS-CoV-2 infection. Additionally, the lack of vaccination in these cases raises the question of whether COVID-19 immunization could reduce SRC risk. Further research is needed to elucidate the pathophysiology, risk stratification, and long-term outcomes of COVID-19-associated SRC, as well as the role of vaccination in prevention. en_US
dc.language.iso en en_US
dc.publisher Instituţia Publică Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu” din Republica Moldova en_US
dc.relation.ispartof Revista de Științe ale Sănătății din Moldova = Moldovan Journal of Health Sciences en_US
dc.subject COVID-19 en_US
dc.subject scleroderma renal crisis en_US
dc.subject systemic sclerosis en_US
dc.subject acute kidney injury en_US
dc.subject SARS-CoV-2 en_US
dc.subject.ddc UDC: 616.98:578.834.1:[616-004.1+616.61-008.64] en_US
dc.title COVID-19 as a possible risk factor for poor prognosis in systemic sclerosis en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account

Statistics